artemether has been researched along with Infections, Plasmodium in 243 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (9.05) | 18.7374 |
| 1990's | 12 (4.94) | 18.2507 |
| 2000's | 61 (25.10) | 29.6817 |
| 2010's | 62 (25.51) | 24.3611 |
| 2020's | 86 (35.39) | 2.80 |
| Authors | Studies |
|---|---|
| Brossi, A; Buchs, P; Dominguez Gerpe, L; Flippen-Anderson, JL; Luo, XD; Milhous, W; Peters, W; Venugopalan, B; Yeh, HJ | 1 |
| Bégué, JP; Bonnet-Delpon, D; Doury, JC; Gantier, JC; Ménage, C; Pradines, B; Thac, TD; Thanh Nga, TT | 1 |
| Ager, AL; Andersen, SL; Dong, Y; Edwards, G; Fu, H; Gerena, L; Holme, AD; Kyle, DE; McLean, WG; Milhous, WK; Miller, RE; Vennerstrom, JL; Walters, SM; Wesche, DL; Wood, JK | 1 |
| Bishop, LP; Hindley, S; Maggs, JL; Miller, A; O'Neill, PM; Park, BK; Posner, GH; Roberts, SM; Scheinmann, F; Stachulski, AV; Ward, SA | 1 |
| Bray, PG; Davies, J; Hindley, S; O'Neill, PM; Park, BK; Searle, NL; Storr, RC; Ward, SA | 1 |
| Bachi, MD; Hoos, R; Korshin, EE; Ploypradith, P; Posner, GH; Shapiro, TA; Szpilman, AM; Xie, S | 1 |
| Bégué, JP; Bonnet-Delpon, D; Charman, WN; Charneau, S; Chorki, F; Crousse, B; Grellepois, F; Grellier, P; McIntosh, KA; Ourévitch, M; Pradines, B | 1 |
| Brun, R; Charman, SA; Charman, WN; Chiu, FC; Chollet, J; Dong, Y; Dorn, A; Karle, JM; Matile, H; Santo Tomas, J; Scheurer, C; Scorneaux, B; Snyder, C; Tang, Y; Urwyler, H; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
| Brun, R; Charman, SA; Charman, WN; Chollet, J; Creek, DJ; Dong, Y; Matile, H; Padmanilayam, M; Scheurer, C; Scorneaux, B; Tomas, JS; Vennerstrom, JL; Wittlin, S | 1 |
| Becker, K; Davioud-Charvet, E; Friebolin, W; Furrer, J; Jannack, B; Lanzer, M; Oeser, T; Sanchez, CP; Wenzel, N; Yardley, V | 1 |
| Chen, X; Hergenrother, PJ; Liu, JO; Posner, GH; Rosenthal, AS; Shapiro, TA; West, DC | 1 |
| Beck, HP; Brun, R; Cohen, SB; Dartois, V; Dharia, NV; Diagana, TT; Fidock, DA; Goh, A; González-Páez, GE; Jegla, T; Keller, TH; Lakshminarayana, SB; Lee, MC; McNamara, C; Nosten, F; Plouffe, DM; Renia, L; Rottmann, M; Russell, B; Schmitt, EK; Seitz, P; Spencer, KR; Suwanarusk, R; Tan, J; Winzeler, EA; Yeung, BK; Zou, B | 1 |
| Amewu, R; Berger, O; Berry, NG; Biagini, GA; Charoensutthivarakul, S; Fisher, NE; Gibbons, P; Hill, A; Hong, WD; Leung, SC; Mbekeani, A; Nixon, GL; O'Neill, PM; Pacorel, B; Pidathala, C; Sharma, R; Shone, AE; Srivastava, A; Stocks, PA; Taylor, L; Ward, SA; Warman, AJ | 1 |
| Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
| Conyers, RC; Mazzone, JR; Posner, GH; Sullivan, DJ; Tripathi, AK | 1 |
| Abuaku, B; Afriyie, PO; Bart-Plange, C; Duah-Quashie, NO; Ghansah, A; Gyasi, A; Koram, KA; Malm, KL; Owusu-Antwi, F; Quashie, N | 1 |
| Apat, D; Carter, J; Igunza, P; Kimori, J; Kinyari, T; Kiplimo, R; Langat, B; Marita, E; Muhula, S | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Amaratunga, C; Callery, JJ; Chau, NH; Chotivanich, K; Chotsiri, P; Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Dung, NTP; Hien, TT; Hoglund, RM; Imwong, M; Lek, D; Long, LT; Maude, RJ; Miotto, O; Mukaka, M; Nghia, HDT; Nguon, C; Peto, TJ; Rekol, H; Ruecker, A; Sokha, M; Sovann, Y; Tarning, J; Thuong, NTH; Tripura, R; van der Pluijm, RW; Van Luong, V; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Bauleni, A; Buchwald, AG; Chilombe, M; Coalson, JE; Cohee, LM; Laufer, MK; Mathanga, DP; Ngwira, A; Peterson, I; Schaffer-DeRoo, S; Seydel, KB; Taylor, TE; Valim, C; Wilson, ML | 1 |
| Bottieau, E; Huits, R; Rosanas-Urgell, A; Tournoy, TK; Van Esbroeck, M | 1 |
| Atieli, H; Debrah, I; Githeko, AK; Githure, J; Kazura, J; Lee, MC; Magomere, EO; Mukabana, WR; Ochwedo, KO; Olumeh, JO; Onyango, P; Otambo, WO; Ouma, C; Wang, C; Yan, G; Zhou, G | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM | 1 |
| Ashaba, FK; Edgar, K; Kamya, MR; Mwesigwa, S; Nsobya, SL; Ocan, M | 1 |
| Grundmann, O; Hernandez Maldonado, J | 1 |
| Balizou, O; Biago, U; Gody, JC; Moyen, M; Nambei, WS; Ndoua, C; Pounguinza, S | 1 |
| Batty, KT; Bwire, GM; Davis, TME; Makani, J; Manning, L; Minzi, OMS; Moore, BR; Ngasala, B; Page-Sharp, M; Salman, S; Sugiarto, SR | 1 |
| Baguiya, A; Barry, N; Burri, C; Dianda, F; Hien, D; Kaboré, JMT; Nombré, Y; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Hezagira, N; Riewpaiboon, A; Youngkong, S | 1 |
| Esfahani, G; Häusler, O; Mäder, K | 1 |
| Adeniji, OE; Amambua-Ngwa, A; Amawu, AU; Correa, S; Faal, F; Heinz, E; Hughes, G; Meremikwu, MM; Oboh, MA; Ogban, E | 1 |
| Amante, FH; Barber, BE; Birrell, GW; Edstein, MD; Gower, J; Heunis, J; Jennings, H; Llewellyn, S; Lynch, S; Marquart, L; McCarthy, JS; Mitchell, H; O'Neill, B; Peters, JM; Potter, AJ; Shanks, GD; Webster, R | 1 |
| Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Abuom, D; Akala, HM; Andagalu, B; Chemwor, G; Cheruiyot, A; Cowden, J; Juma, D; Kamau, E; Ogutu, B; Okoth, R; Okudo, C; Onyango, I; Opot, B; Sifuna, P; Wafubwa, J; Watson, OJ; Yalwala, S; Yeda, R | 1 |
| Amambua-Ngwa, A; Bojang, F; D'Alessandro, U; Demba, MA; Diop, MF; Jeffries, D; Mane, K; Mbye, H; Mohammed, NI; Quashie, NB | 1 |
| Abdallah, KS; Bacar, A; Deng, C; Li, G; Li, M; Liu, R; Lu, C; Silai, R; Song, J; Tan, R; Wu, W; Xu, Q; Yuan, Y; Zhang, H; Zheng, S | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jaiteh, FK; Oboh, M; Oriero, E; Tadele, G | 1 |
| Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N | 1 |
| Barnes, KI; Berghmans, PJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Escoffier, E; Flynn, J; Gobeau, N; Izquierdo-Juncàs, D; Jansen, B; Kümmel, A; Marx, MW; Mitov, V; Möhrle, JJ; Rosanas-Urgell, A; Van Geertruyden, JP; Van Leuven, K | 1 |
| Kamugisha, E; Konje, ET; Liwa, AC; Marwa, KJ; Mwita, S; Swedberg, G | 1 |
| Aweeka, FT; Colt, M; Goodwin, J; Huang, L; Kajubi, R; Li, F; Mwebaza, N; Orukan, F; Parikh, S; Richards, K; Wang, K; Whalen, ME | 1 |
| Callery, JJ; Chotthanawathit, P; Conradis-Jansen, F; Dondorp, AM; Duanguppama, J; Ean, M; Heng, C; Imwong, M; Jongdeepaisal, M; Khonputsa, P; Madmanee, W; Maude, RJ; Mukaka, M; Peerawaranun, P; Pell, C; Peto, TJ; Pongsoipetch, K; Rekol, H; Sokha, M; Sovannaroth, S; Soviet, U; Tarning, J; Tripura, R; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Dondorp, AM; Maude, RJ; Tarning, J; von Seidlein, L; White, NJ | 1 |
| Alemayehu, GS; Dinka, H; Golassa, L; Hassen, J | 1 |
| Aweeka, F; Ehrlich, H; Freeman, T; French, J; Goodwin, J; Huang, L; Kajubi, R; Kay, K; Li, F; Mwebaza, N; Ou, J; Parikh, S; Riggs, M; Ruiz-Garcia, A; Wade, M; Wang, K | 1 |
| Bibe, AF; Earland, DE; Ferrão, J; Novela, A; Searle, KM | 1 |
| Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R | 1 |
| Bhide, AR; Dighe, VD; Jindal, AB; Jirwankar, YB; Katnoria, S; Kaur, S; Suri, M | 1 |
| Augusto, O; Byamugisha, J; Clerk, C; Dellicour, S; Desai, M; Gomes, M; Guérin, PJ; Hill, J; Kagawa, M; Kariuki, S; Kisinza, W; Manyando, C; McGready, R; Mehta, U; Mosha, D; Mrema, S; Njunju, EM; Nosten, F; Rouamba, T; Rulisa, S; Saito, M; Sevene, E; Singlovic, J; Stepniewska, K; Stergachis, A; Ter Kuile, FO; Tinto, H; Vala, A; van Eijk, AM; Were, E; Yore, M | 1 |
| He, Z; Hu, J; Huang, Q; Li, X; Liang, J; Liao, X; Pan, Z; Ru, L; Song, J; Xu, Q; Yu, C; Yu, W; Zeng, F; Zhang, X | 1 |
| Adams, M; Buchwald, AG; Divala, TH; Earland, DE; Laufer, MK; Laurens, MB; Mallewa, JE; Miller, J; Mungwira, RG; Nampota-Nkomba, N; Nyangulu, W; Nyirenda, OM; Parikh, S; Plowe, CV; Taylor, TE; van Oosterhout, JJ | 1 |
| Mace, KE; Schultz, JS; Tan, KR | 1 |
| Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F | 1 |
| Batty, KT; Davis, TME; Kasian, B; Laman, M; Lorry, L; Manning, L; Moore, BR; Pomat, W; Robinson, LJ; Salman, S; Tesine, P; Woon, SA; Yadi, G; Yambo, P | 1 |
| Ashton, RA; Bennett, A; Burnett, S; Eisele, TP; Hainsworth, M; Hamainza, B; Lungu, C; Miller, JM; Porter, T; Rutagwera, MI; Silumbe, K; Slater, H | 1 |
| Abala, C; Nyeko, R; Obiya, EM; Otim, F | 1 |
| Bogoch, II; Halani, S | 1 |
| Ahmed, RA; Begum, A; Hussain, SSA; Kalita, D; Kumar, A; Kumar, G; Shankar, H; Singh, K; Suri, HS; Swargiary, A | 1 |
| Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA | 1 |
| Aygen, B; Kalın Ünüvar, G; Türe, Z; Yaman, O; Yıldız, O | 1 |
| Djissem, PE; Manyeh, AK; Tetteh, JA | 1 |
| Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| Agyemang, SA; Aikins, M; Amon, S; Aryeetey, GC; Baabu, BS; Dwomoh, D; Malm, K; Nonvignon, J; Novignon, J; Owusu, R; Peprah, NY | 1 |
| Buzibye, A; Nakalembe, L; Nsobya, S; Ocan, M; Omali, D; Otike, C | 1 |
| Adebanjo, IM; Ademowo, OG; Ajayi, AM | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G | 1 |
| Adhikari, B; Callery, JJ; Cheah, PY; Conradis-Jansen, F; Dondorp, AM; Ean, M; Jongdeepaisal, M; Khonputsa, P; Maude, RJ; Müller, O; Murgia, R; Pell, C; Peto, TJ; Sovannaroth, S; Tripura, R; von Seidlein, L | 1 |
| Chikoto, H; Csermak, K; Demin, I; El Gaaloul, M; Fofana, B; Grobusch, MP; Kaguthi, G; Kibuuka, A; Kusemererwa, S; Lingani, M; Lourenço, C; Marrast, AC; Mehta, D; Mombo-Ngoma, G; N'Guessan, TL; Nassa, GJW; Nduba, V; Nyantaro, M; Ogutu, B; Pathan, R; Risterucci, C; Singh, PK; Su, G; Thompson, R; Tina, LO; Tinto, H; Toure, AO; Uthaisin, C; Verma, A; Winnips, C; Yeka, A | 1 |
| Bernieri, F; Cavallari, S; Doderer-Lang, C; Guidetti, C; L'Episcopia, M; Menard, D; Perrotti, E; Priuli, GB; Severini, C | 1 |
| Abel, L; Ambani, G; Boyce, M; Kirui, J; Laktabai, J; Malinga, J; Menya, D; Nalianya, E; Namae, J; O'Meara, W; Sang, E | 1 |
| Ayrık Demir, A; Erdoğan, E; Türe Yüce, Z; Yaman, O; Yıldız, O; Yürük, M | 1 |
| Aide, P; Baraka, V; Bassat, Q; Cousin, M; David, A; Gesase, S; Gwasupika, J; Hachizovu, S; Makenga, G; Manyando, C; Nhama, A; Ntizimira, CR; Obunge, O; Otsyula, N; Pathan, R; Risterucci, C; Su, G; Tshefu, KA | 1 |
| Bauserman, M; Laktabai, J; Rent, S; Taylor, SM; Tshefu, AK | 1 |
| Dellicour, S; Gutman, JR; Hill, J; Ochodo, E; Osoro, CB; Ter Kuile, F; Young, T | 1 |
| Dellicour, S; Gutman, JR; Hill, J; Ochodo, E; Osoro, CB; Ter Kuile, FO; Young, T | 1 |
| Ahmed, K; Culleton, R; Dony, JJF; Fornace, KM; Habil, B; Hassan, MR; Hod, R; Ibrahim, SSA; Jantim, A; Jeffree, MS; Jiee, SF; Mohamed, AFB; Naserrudin, NA | 1 |
| D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A | 1 |
| Abade, A; O'Meara, WP; Odhiambo, F; Odhiambo, FO; Owiny, M; Oyugi, EO | 1 |
| Acharya, S; Arnold, L; Chico, RM; Gore-Langton, GR; Lufele, E; Moore, BR; Price, RN; Rogerson, SJ; Ter Kuile, FO; Thriemer, K; Unger, HW; van Eijk, AM; Wu, C | 1 |
| Angora, ÉK; Bedia-Tanoh, VA; Bosson-Vanga, H; Djohan, V; Kassi, FK; Kiki-Barro, PCM; Konaté-Touré, A; Koné-Bravo, EDM; Menan, HEI; Miezan, SAJ; Yavo, W | 1 |
| Ahoua Alou, LP; Camara, S; Koffi, AA; N'Guessan, B; N'Guessan, R; Oumbouke, WA; Rowland, M; Thomas, MB; Tia, IZ; Wolie, RZ; Zoh, MG | 1 |
| Abate, DT; Alam, MS; Anose, RT; Baird, JK; Christian, M; Degaga, TS; Ekawati, LL; Hailu, A; Hossain, MS; Karahalios, A; Kibria, MG; Kiros, FG; Lee, G; Ley, B; Mnjala, H; Panggalo, LV; Price, RN; Rajasekhar, M; Rumaseb, A; Sadhewa, A; Satyagraha, AW; Simpson, JA; Sutanto, I; Tego, TT; Thriemer, K; Weston, S; Woyessa, A | 1 |
| Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S | 1 |
| Adegbola, AJ; Bolaji, OO; Hassan, IA; Onyeji, CO; Soyinka, JO | 1 |
| Clark, RL | 1 |
| Iribhogbe, OI; Odoya, EM | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Cargill, Z; Chu, C; Gilder, ME; McGready, R; Min, AM; Nosten, F; Phyo, AP; Poe, H; Saito, M; San, TD; White, NJ; Yotyingaphiram, W | 1 |
| Boateng-Marfo, Y; Dong, Y; Lin, HS; Ng, WK | 1 |
| Baguiya, A; Barry, N; Dianda, F; Héma, A; Hien, D; Kaboré, JMT; Kiba Koumaré, A; Kouanda, S; Nombré, Y; Savadogo, Y; Siribie, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C | 1 |
| Abba, T; Angora, EK; Assi, SB; Bedia, VA; Daho, AK; Emmanuel, B; Kiki-Barro, PMC; Konate, AA; Menan, H; Tiacoh, LN; Toure, OA; Yavo, W | 1 |
| Beshir, KB; Chijioke-Nwauche, I; Nwauche, CA; Oguike, MC; Sutherland, CJ | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Dong, X; Gong, M; Gu, L; Li, J; Wang, M; Zhang, X | 1 |
| Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B | 1 |
| Callery, JJ; Ean, M; Imwong, M; Maude, RJ; Mukaka, M; Peto, TJ; Sokha, M; Sovannaroth, S; Soviet, O; Tarning, J; Tripura, R; von Seidlein, L; Vongpromek, R; Waithira, N | 1 |
| Davis, TME; Davis, WA; Hii, KC; Page-Sharp, M; Salman, S; Singh, B; Sugiarto, SR | 1 |
| Achan, J; Biculu, J; Bukoma, P; Ediamu, T; Gudoi, S; Mulebeke, R; Musiime, A; Nantanda, R; Tibenderana, JK; Tumwine, D; Wanzira, H | 1 |
| Álvarez-Larrotta, C; Aponte, S; Bernal, SD; González, C; Guerra, ÁP; Knudson-Ospina, A; Restrepo, C; Yasnot, MF | 1 |
| Chow, SC; Yuan, M; Zheng, J | 1 |
| Alonso, S; Munguambe, K; Sicuri, E | 1 |
| Ahmad, FJ; Ali, S; Imam, SS; Jain, GK; Rahman, MA; Raisuddin, S; Shakeel, K | 1 |
| Grzesiak, M; Krekora, M; Respondek-Liberska, M; Słodki, M; Zych-Krekora, K | 1 |
| Antunes, LR; Grabe-Guimarães, A; Guimarães, HN; Mosqueira, VCF; Richard, S; Silveira, APA; Souza, ACM | 1 |
| César, IC; Fernandes, C; Pianetti, GA; Ricoy, LBM; Rivelli, GG | 1 |
| Gao, H; Kuang, X; Liu, H; Sun, J; Wang, Z; Yang, Y; Zhou, S | 1 |
| Bringmann, G; Feineis, D; Hoellein, L; Holzgrabe, U; Mufusama, JP; Ndjoko Ioset, K | 1 |
| Dias, S; Donegan, S; Welton, NJ | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Bierhoff, M; Grobusch, MP; van Gool, T; van Hattem, JM; van Vugt, M; Visser, BJ | 1 |
| DeMasi, R; Kakuda, TN; Mohammed, P; van Delft, Y | 1 |
| Osonuga, A; Osonuga, AA; Osonuga, IO; Osonuga, OA | 1 |
| Adaramoye, OA; Ademowo, OG; Falade, CO; Nneji, CM | 1 |
| Pathak, S; Patil, S; Patravale, V; Sharma, S; Suryavanshi, S | 1 |
| Häussinger, D; Henrich, B; Holtfreter, MC; Imwong, M; Jensen, BO; Kocheril, SJ; MacKenzie, C; Mallach, S; Müller-Stöver, I; Orth, H; Richter, J; White, NJ | 1 |
| Conyers, RC; Mazzone, JR; Mott, BT; Posner, GH; Siegler, MA; Sullivan, DJ; Tripathi, AK | 1 |
| Abiodun, OO; Akinbo, J; Ojurongbe, O | 1 |
| Ba, BB; Boiron, JM; Fabre, JL; Fawaz, F; Gaubert, A; Gaudin, K; Grislain, L; Kauss, T; Lafarge, X; Lembege, M; Lindegardh, N; Marchivie, M; Millet, P; Olliaro, PL; White, NJ | 1 |
| Ademowo, OG; Dada-Adegbola, HO; Falade, CO; Nash, O; Oguike, MC; Ogunkunle, OO | 1 |
| Aditya, NP; Murthy, RS; Parashar, D | 1 |
| Adriko, M; Arinaitwe, M; Atuhaire, A; Betson, M; Kabatereine, NB; Mwesigwa, G; Nabonge, J; Sousa-Figueiredo, JC; Stothard, JR; Sutherland, CJ | 1 |
| Chen, T; Lu, T; Ma, Y; Mei, Q; Wang, Y; Zhao, W | 1 |
| Bruxvoort, K; Cairns, M; Festo, C; Goodman, C; Kachur, SP; Kalolella, A; Kenani, M; Lyaruu, P; Schellenberg, D | 1 |
| Ding, GY; Huang, JC; Li, XB; Shi, YX; Su, JK; Zheng, K | 1 |
| Abiodun, OO; Akinola, O; Badejo, JA; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Emeje, M; Ezenyi, IC; Kulkarni, R; Salawu, OA | 1 |
| Corsello, MA; Garg, NK | 1 |
| Blagborough, AM; Brock, PM; Churcher, TS; Delves, MJ; Gething, PW; Ghani, AC; Leroy, D; Sala, KA; Sinden, RE; Upton, LM | 1 |
| Agubata, CO; Attama, AA; Mueller-Goymann, CC; Nzekwe, IT; Onunkwo, GC | 1 |
| Bendel, D; Davis, TM; Lee, TC; Salman, S; Templeton, D | 1 |
| Diarra, A; Siribié, M; Sirima, SB; Soulama, I; Tiono, AB | 1 |
| Aklillu, E; Kamuhabwa, AA; Maganda, BA; Minzi, OM; Ngaimisi, E | 1 |
| Jones, C; Okiro, EA; Snow, RW; Todd, J; Wasunna, B; Webster, J | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Kakoko, D; Simba, D | 1 |
| Cohen, J; Kasozi, H; Saran, I; Yavuz, E | 1 |
| Chen, A; Gallien, J; Leung, NH; Yadav, P | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
| Awale, M; Jain, SA; Pathak, S; Patravale, VB; Sharma, S; Vanage, G | 1 |
| Pathak, S; Patravale, V; Prabhu, P; Sharma, S; Suryavanshi, S | 1 |
| Awano, T; Baba, ES; Batisso, E; Edossa, W; Getachew, D; Hamade, P; Kebede, Z; Kefyalew, T; Mekonnen, E; Mukanga, D; Nankabirwa, JI; Shumba, C; Tekalegne, A; Tibenderana, J | 1 |
| Allan, R; Floridia, M; Fortes, F; Lussiana, C; Martinho do Rosário, J | 1 |
| Bekkali, H; Belkouch, A; Belyamani, L; Jidane, S; Zidouh, S | 1 |
| Desai, P; Dhumatkar, R; Gaud, RS; Shende, P | 1 |
| Sullivan, DJ; Walker, LA | 1 |
| Adjuik, M; Amenga-Etego, S; Asante, KP; Chandramohan, D; Dosoo, DK; Greenwood, B; Gyapong, J; Owusu, R; Owusu-Agyei, S | 1 |
| Joshi, M; Pathak, S; Patravale, V; Sharma, S | 2 |
| Mandawgade, SD; Pathak, S; Patravale, VB; Sharma, S | 1 |
| Meek, S; Nankabirwa, J; Njogu, JN; Rwakimari, JB; Snow, RW; Ssekitooleko, J; Talisuna, A; Tibenderana, JK; Zurovac, D | 1 |
| Barennes, H; Dembele, EM; Diakite, C; Diallo, D; Dicko, M; Falquet, J; Forster, M; Giani, S; Graz, B; Lambert, B; Willcox, ML | 1 |
| Dorsey, G; Nosten, F; Price, RN | 1 |
| Campagna, AM; Patnaik, MM | 1 |
| Banura, P; Jacob, ST; Kenya-Mugisha, N; Mayanja-Kizza, H; Meya, DB; Moore, CC; Pinkerton, R; Reynolds, SJ; Scheld, WM | 1 |
| Thompson, CA | 1 |
| Aweeka, FT; Huang, L; Jayewardene, AL; Li, X; Lizak, PS; Marzan, F | 1 |
| Amos, B; Hendriksen, I; Mandea, V; Manjurano, A; Mapunda, E; Mrema, H; Mtove, G; Reyburn, H; Rutta, B; Sykes, A; Whitty, CJ | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| Efferth, T; Kaina, B | 1 |
| Aditya, NP; Madhusudhan, B; Murthy, RS; Patankar, S; Souto, EB | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Arinaitwe, E; Bigira, V; Creek, D; Dorsey, G; Kakuru, A; Kamya, MR; Sandison, TG; Tappero, J; Wanzira, H | 1 |
| Anstey, NM; Chan, L; Donaldson, S; Frederick, C; Jelip, J; Khoo, S; Ma, G; Menon, J; Rajahram, G; William, T; Yeo, TW | 1 |
| Chin, LC; Fong, MY; Lau, YL; Noraishah, MA; Rohela, M; Tan, LH | 1 |
| Davis, TM; Griffin, S; Ilett, KF; Kose, K; Mueller, I; Page-Sharp, M; Salman, S; Siba, PM | 1 |
| Arguin, PM; Doney, AC; Galev, A; Green, M; Kapella, BK; Mekonnen, L; Phares, CR; Stauffer, WM; Weinberg, M | 1 |
| Denholm, J; Shortt, J; Smith, A; Spelman, D | 1 |
| Franken, G; Häussinger, D; Holtfreter, MC; Labisch, A; Mehlhorn, H; Müller-Stöver, I; Richter, J; Walter, S | 1 |
| Joshi, M; Pathak, S; Patil, S; Patravale, V; Sharma, S | 1 |
| Gettayacamin, M; Kyle, DE; Li, QG; Milhous, WK; Mog, SR; Si, YZ | 1 |
| Kager, PA | 1 |
| Marsh, K | 1 |
| Brasseur, P; Chippaux, JP; Garcia, A; Le Hesran, JY | 1 |
| Afzal, K; Ali, SM; Huda, SN; Khan, HM; Shahab, T | 1 |
| Cai, Y; Chollet, J; Tanner, M; Utzinger, J; Xiao, SH; Yao, JM | 1 |
| Arai, M; Ishii, A; Matsuoka, H | 1 |
| Gamble, C; Garner, P; Omari, AA | 1 |
| Bégué, JP; Bonnet-Delpon, D; Charneau, S; Crousse, B; Grellier, P; Magueur, G | 1 |
| Majori, G | 1 |
| Stingl, P | 1 |
| Garner, P; Omari, A | 4 |
| Guo, J; Ni, YC; Wang, QM; Wu, JT | 1 |
| Ansah, E; Reyburn, H; Whitty, CJ | 1 |
| Chan, HW; Gerena, L; Haynes, RK; Ho, WY; Ko, CK; Kyle, DE; Peters, W; Robinson, BL | 1 |
| Balasegaram, M; Davidson, R; Dejene, S; Perkins, S; Tinnemann, P | 1 |
| Arunkamomkiri, J; Ashley, E; Carrara, VI; Htoo, H; Hutagalung, R; Nosten, F; Nwee, P; Singhasivanon, P; White, NJ; Zwang, J | 1 |
| Chollet, J; Shu-Hua, X; Tanner, M; Utzinger, J | 1 |
| Chinbuah, AM; Gyapong, JO; Gyapong, M; Pagnoni, F; Wellington, EK | 1 |
| Alecrim, Md; Alecrim, WD; Boulos, M; Cardoso, B; de Lacerda, MV; Mourão, MP; Padilha, A | 1 |
| Akhwale, W; Larson, BA; Snow, RW; Zurovac, D | 1 |
| Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
| Adeoshun, IO; Akanji, BO; Akomolafe, RO; Ayoka, AO; Fakunle, JB; Iwalewa, EO | 1 |
| Davis, TM; Ilett, KF; Karunajeewa, HA; Manning, L; Mueller, I | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Agbodjan-Djossou, A; Azoumah, KD; Balaka, B; Djadou, D; Djadou, KE; Komlangan, A; Lawson-Evi, K | 1 |
| Hopkins, H; Lubell, Y; Mills, A; Staedke, SG; Whitty, CJ | 1 |
| Goodman, CA; Snow, RW; Wasunna, B; Zurovac, D | 1 |
| Ahmadi, M; El-Bahnasawy, M; Gouda, H; Ibrahim, A; Shahat, SA; Zaher, T | 1 |
| Kuhn, T; Wang, Y | 1 |
| Chen, LJ; Gu, HM; Ji, RY; Liu, MZ; Lu, BF; Sun, WK; Wang, MY; Xu, B; Xu, JY | 1 |
| Chen, KY; Lin, BY; Ye, XY; Zhang, JX; Zheng, H | 1 |
| Guo, XB; Jian, HX; Jin, R; Li, GQ; Li, ZY; Wang, ZC | 1 |
| Li, GQ | 1 |
| Boecken, GH; Lademann, M | 1 |
| Ager, AL; Klayman, DL; Lin, AJ | 1 |
| Chen, YD; Lin, BY; Pan, YR; Tang, WZ; Xu, B; Zhang, JX; Zheng, H | 1 |
| Fang, Y; Lin, BY; Pan, YR; Zhang, JX; Zheng, H | 1 |
| Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
| Ambroise-Thomas, P | 2 |
| Ezzet, F; Karbwang, J; Mull, R | 1 |
| Ernst, E; Pittler, MH | 1 |
| Boele van Hensbroek, M | 1 |
| Nosten, F; van Vugt, M; White, NJ | 1 |
| Ezzet, F; van Vugt, M; White, NJ | 1 |
| Takeuchi, T | 1 |
| MacDonald, RD | 1 |
| Ishiyama, A; Kohana, A; Manabe, C; Omura, S; Otoguro, K; Shiomi, K; Ui, H; Yamada, H | 1 |
| Bringmann, G; Chimanuka, B; François, G; Heyden, YV; Holenz, J; Plaizier-Vercammen, J; Timperman, G | 1 |
| Chimanuka, B; Detaevernier, MR; Gabriëls, M; Plaizier-Vercammen, JA | 1 |
| Wang, TY | 1 |
| Li, XY; Liang, HZ | 1 |
| Cai, Y; Li, AY; Xie, PS; Xuan, WY; Zhao, Y | 1 |
| Pang, XJ | 1 |
| Feng, TG; Guo, XB; Li, GQ; Li, PS; Shi, WZ; Wang, HF; Zhang, SF | 1 |
| Du, YL; Jiang, Q; Li, CS | 1 |
| Li, ZL; Peters, W; Robinson, BL; Warhurst, DC | 1 |
| Gu, HM; Waki, S; Zhu, MY | 1 |
| Cai, XZ; He, XZ; Yang, XP; Ye, BS; Zhan, WC; Zhan, X | 1 |
| Wang, TY; Xu, RC | 1 |
26 review(s) available for artemether and Infections, Plasmodium
| Article | Year |
|---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum | 2022 |
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
Topics: Abortion, Spontaneous; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Quinine; Stillbirth | 2023 |
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Asia; Female; Humans; Lactation; Malaria; Malaria, Falciparum; Pregnancy | 2023 |
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Microbial; Malaria; Molecular Structure; Plasmodium falciparum | 2015 |
Toxicity of the antimalarial artemisinin and its dervatives.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Developing Countries; Dogs; Drug Administration Routes; Drug-Related Side Effects and Adverse Reactions; Humans; Malaria; Rabbits; Rats; Sesquiterpenes | 2010 |
[Three newly registered drugs in the Netherlands for the treatment and chemoprophylaxis of malaria: atovaquone-proguanil, artemether-lumefantrine and artemotil].
Topics: Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Approval; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Naphthoquinones; Netherlands; Proguanil; Sesquiterpenes; Treatment Outcome | 2003 |
Artemesinins for severe malaria in Africa?
Topics: Adult; Antimalarials; Artemether; Artemisia; Artemisinins; Child; Drug Evaluation; Humans; Malaria; Phytotherapy; Sesquiterpenes | 2002 |
Artemether-lumefantrine for uncomplicated malaria: a systematic review.
Topics: Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Parasitemia; Randomized Controlled Trials as Topic; Sesquiterpenes; Treatment Outcome | 2004 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Climate; Doxycycline; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Mefloquine; Naphthoquinones; Pregnancy; Proguanil; Risk Factors; Self Medication; Sesquiterpenes; Time Factors; Travel | 2004 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Malaria: severe, life threatening.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Humans; Malaria; Malaria, Falciparum; Quinine; Sesquiterpenes | 2004 |
Malaria: severe, life threatening.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Humans; Malaria; Quinine; Sesquiterpenes | 2004 |
Malaria: severe, life threatening.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria; Quinine; Sesquiterpenes | 2006 |
Rectal administration of artemisinin derivatives for the treatment of malaria.
Topics: Administration, Rectal; Area Under Curve; Artemether; Artemisinins; Artesunate; Humans; Malaria; Sesquiterpenes | 2007 |
Artemisinin--an innovative cornerstone for anti-malaria therapy.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisia annua; Artemisinins; Biomass; Crops, Agricultural; Drug Combinations; Drug Design; Drug Resistance; Drugs, Chinese Herbal; Ethanolamines; Fluorenes; Humans; Malaria; Models, Molecular; Molecular Structure; Technology, Pharmaceutical; Treatment Outcome | 2008 |
[Intra-muscular artemether in the treatment of severe malaria: synthesis of current results].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Resistance; Humans; Infusions, Intravenous; Injections, Intramuscular; Malaria; Quinine; Research Design; Sesquiterpenes; Survival Analysis; Treatment Outcome | 1997 |
Artemether for severe malaria: a meta-analysis of randomized clinical trials.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria; Odds Ratio; Quinine; Sesquiterpenes | 1999 |
The role of the qinghaosu derivatives in the treatment of severe malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Child; Humans; Malaria; Quinine; Research Design; Sesquiterpenes | 1998 |
Intrarectal artemisinin derivatives.
Topics: Absorption; Administration, Rectal; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria; Metabolic Clearance Rate; Sesquiterpenes; Suppositories | 1998 |
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Food-Drug Interactions; Humans; Lumefantrine; Malaria; Plasmodium falciparum; Sesquiterpenes | 1999 |
[Treatment of malaria: prevention of resistance by combinations of antimalarial agents].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthyridines; Plasmodium; Sesquiterpenes | 2000 |
[Malaria].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Diagnosis, Differential; Humans; Malaria; Prognosis; Sesquiterpenes | 2001 |
41 trial(s) available for artemether and Infections, Plasmodium
| Article | Year |
|---|---|
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Vomiting | 2022 |
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Parasitemia; Parasites; Plasmodium falciparum; Sporozoites | 2022 |
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Parasitemia; Prospective Studies; Reinfection; Uganda | 2023 |
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cambodia; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum | 2023 |
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum | 2022 |
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia | 2022 |
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Treatment Outcome | 2023 |
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium vivax; Primaquine; Time-to-Treatment | 2023 |
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies | 2023 |
Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Forests; Humans; Malaria | 2023 |
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2023 |
Supply-side and demand-side factors influencing uptake of malaria testing services in the community: lessons for scale-up from a post-hoc analysis of a cluster randomised, community-based trial in western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Community Health Services; Community Health Workers; Fever; Humans; Kenya; Malaria; Research Design | 2023 |
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome | 2023 |
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Primaquine | 2023 |
Randomized Controlled Trial of the Electrocardiographic Effects of Four Antimalarials for Pregnant Women with Uncomplicated Malaria on the Thailand-Myanmar Border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria; Malaria, Falciparum; Myanmar; Pregnancy; Pregnant Women; Quinolines; Thailand | 2021 |
Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Outcome | 2020 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines | 2021 |
Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cambodia; Forests; Humans; Malaria; Malaria, Falciparum; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Cross-Over Studies; Darunavir; Drug Interactions; Ethanolamines; Fluorenes; Healthy Volunteers; HIV; HIV Infections; Humans; Lumefantrine; Malaria; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Ritonavir; Sulfonamides | 2013 |
Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Genome, Protozoan; Humans; Infant; Lumefantrine; Malaria; Male; Nigeria; Polymerase Chain Reaction | 2014 |
Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Commerce; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria; Male; Patient Compliance; Plasmodium; Tanzania; Text Messaging | 2014 |
Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria.
Topics: Administration, Sublingual; Africa; Antimalarials; Artemether; Artemisinins; Child, Preschool; Female; Humans; Infant; Malaria; Male | 2015 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Can Rapid Diagnostic Testing for Malaria Increase Adherence to Artemether-Lumefantrine?: A Randomized Controlled Trial in Uganda.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Medication Adherence; Point-of-Care Testing; Uganda | 2016 |
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Polymerase Chain Reaction; Proguanil; Treatment Outcome | 2008 |
Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
Topics: Administration, Sublingual; Adolescent; Antimalarials; Artemether; Artemisinins; Blood Glucose; Child; Child, Preschool; Female; Glucose; Humans; Hypoglycemia; Infant; Infusions, Intravenous; Injections, Intramuscular; Malaria; Male; Mali; Pilot Projects; Rural Health; Treatment Outcome | 2008 |
Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria.
Topics: Adult; Anti-Infective Agents; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Prospective Studies; Sepsis; Uganda; Young Adult | 2009 |
Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fever of Unknown Origin; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Tanzania; Treatment Outcome | 2009 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Quinolines; Risk; Uganda; Vomiting | 2010 |
Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male | 2011 |
A comparative clinical trial of artemether and quinine in children with severe malaria.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Male; Prospective Studies; Quinine; Sesquiterpenes; Survival Analysis; Treatment Outcome | 2003 |
Antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Erythrocytes; Malaria; Mice; Multicenter Studies as Topic; Plasmodium; Sesquiterpenes | 1982 |
Clinical studies on the treatment of malaria with qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria; Multicenter Studies as Topic; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes | 1982 |
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Sesquiterpenes; Treatment Outcome | 1998 |
Artemether for severe malaria: a meta-analysis of randomized clinical trials.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria; Odds Ratio; Quinine; Sesquiterpenes | 1999 |
The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Quinine; Quinolines; Sesquiterpenes | 1988 |
A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrans; Quinine; Sesquiterpenes; Time Factors | 1987 |
177 other study(ies) available for artemether and Infections, Plasmodium
| Article | Year |
|---|---|
Arteether, a new antimalarial drug: synthesis and antimalarial properties.
Topics: Animals; Antimalarials; Artemisinins; Magnetic Resonance Spectroscopy; Malaria; Mice; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes | 1988 |
Synthesis and antimalarial activities of fluoroalkyl derivatives of dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Drug Evaluation, Preclinical; Female; Inhibitory Concentration 50; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1998 |
Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes.
Topics: Alkanes; Animals; Antimalarials; Malaria; Mice; Neurites; Neuroblastoma; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Bile; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radicals; Malaria; Male; Mice; Phenyl Ethers; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2001 |
Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.
Topics: Animals; Antimalarials; Artemisinins; Heterocyclic Compounds, 4 or More Rings; Malaria; Male; Mice; Piperazines; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes | 2002 |
A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic beta-sulfonyl-endoperoxides.
Topics: Animals; Antimalarials; Bridged Bicyclo Compounds, Heterocyclic; Malaria; Male; Mice; Mice, Inbred ICR; Plasmodium berghei; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Sulfones | 2003 |
Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Biological Availability; Drug Resistance; Drug Stability; Heterocyclic Compounds, 4 or More Rings; Hydrolysis; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2004 |
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.
Topics: Adamantane; Animals; Antimalarials; Cell Line, Tumor; Drug Resistance; Half-Life; Malaria; Malaria, Falciparum; Mice; Micronucleus Tests; Ozone; Peroxides; Plasmodium berghei; Rats; Spiro Compounds; Structure-Activity Relationship | 2005 |
Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidine.
Topics: Amines; Animals; Antimalarials; Humans; Malaria; Mice; Microsomes, Liver; Piperidines; Plasmodium berghei; Sulfonamides; Urea | 2006 |
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Topics: Animals; Antimalarials; Biological Transport; Cell Line, Tumor; Chloroquine; Drug Resistance; Drug Therapy, Combination; Glutathione Reductase; Humans; In Vitro Techniques; Malaria; Mice; Mice, Inbred BALB C; Naphthalenes; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2008 |
Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells.
Topics: Administration, Oral; Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Stability; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Mice; Sulfones | 2009 |
Spiroindolones, a potent compound class for the treatment of malaria.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Cell Line; Drug Discovery; Drug Resistance; Erythrocytes; Female; Genes, Protozoan; Humans; Indoles; Malaria; Male; Mice; Models, Molecular; Mutant Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Protein Synthesis Inhibitors; Protozoan Proteins; Rats; Rats, Wistar; Spiro Compounds | 2010 |
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Crystallography, X-Ray; Cytochromes b; Drug Design; Drug Resistance; Humans; Malaria; Male; Mice; Microsomes, Liver; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyridines; Quinolones; Quinone Reductases; Rats; Structure-Activity Relationship | 2012 |
Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Dimerization; Malaria; Mice; Plasmodium berghei | 2015 |
Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Failure | 2021 |
Implementation of community case management of malaria in malaria endemic counties of western Kenya: are community health volunteers up to the task in diagnosing malaria?
Topics: Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Case Management; Community Health Workers; Diagnostic Tests, Routine; Female; Humans; Kenya; Malaria; Middle Aged; Public Health; Volunteers | 2022 |
School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi.
Topics: Anemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Prevalence; Prospective Studies; Schools | 2022 |
Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Fluorenes; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Plasmodium malariae | 2022 |
Health care provider practices in diagnosis and treatment of malaria in rural communities in Kisumu County, Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Diagnostic Tests, Routine; Fever; Health Personnel; Humans; Kenya; Malaria; Malaria, Falciparum; Real-Time Polymerase Chain Reaction; Rural Population; Sensitivity and Specificity | 2022 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence | 2022 |
Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Malaria; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Prevalence; Protozoan Proteins; Uganda | 2022 |
[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Central African Republic; Child; Cross-Sectional Studies; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Mutation; Treatment Outcome | 2021 |
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children.
Topics: Anemia, Sickle Cell; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Tanzania | 2022 |
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burkina Faso; Child; Cross-Sectional Studies; Female; Fever; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy | 2022 |
Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burundi; Case Management; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Malaria | 2022 |
Controlled release starch-lipid implant for the therapy of severe malaria.
Topics: Artemether; Delayed-Action Preparations; Humans; Lactic Acid; Lipids; Malaria; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Starch | 2022 |
Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa.
Topics: Abortion, Spontaneous; Adult; Africa, Western; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Drug Resistance, Multiple; Female; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Pregnant Women; Quinine | 2022 |
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Topics: Adult; Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Healthy Volunteers; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Sporozoites | 2023 |
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines | 2022 |
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Humans; Kenya; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gambia; Ligands; Lumefantrine; Malaria; Malaria, Falciparum; Merozoites; Plasmodium falciparum; Protozoan Proteins | 2022 |
Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Disease Progression; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Sudan; Treatment Outcome | 2022 |
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection | 2022 |
Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Tanzania; Treatment Outcome | 2022 |
High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Genotype; Health Facilities; Humans; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins | 2022 |
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; HIV Infections; Humans; Lopinavir; Lumefantrine; Malaria; Malaria, Falciparum; Nevirapine; Ritonavir; Uganda | 2023 |
Plasmodium falciparum community prevalence and health-seeking behaviours in rural Sussundenga District, Mozambique.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Malaria; Malaria, Falciparum; Mozambique; Patient Acceptance of Health Care; Plasmodium falciparum; Prevalence | 2022 |
Evaluation of Pharmacokinetics, Biodistribution, and Antimalarial Efficacy of Artemether-Loaded Polymeric Nanorods.
Topics: Animals; Antimalarials; Artemether; Malaria; Mice; Nanotubes; Rats; Tissue Distribution | 2023 |
Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection.
Topics: Animals; Artemether; Biomimetics; Erythrocyte Membrane; Erythrocytes; Malaria; Merozoites; Mice; Mice, Inbred C57BL; Phosphatidylserines; Plasmodium berghei; Plasmodium falciparum | 2023 |
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; COVID-19 Testing; Early Diagnosis; Humans; Malaria; Malaria, Falciparum; Pandemics; Travel; United States | 2023 |
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system data.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Case Management; Child; Community Health Workers; Health Information Systems; Humans; Inpatients; Malaria; Retrospective Studies; Zambia | 2023 |
Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Fever; Humans; Malaria | 2023 |
Weight-related malaria treatment failure with artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Treatment Failure | 2023 |
Impact assessment of Intensified Malaria Control Project in transitioning a high malaria-endemic district to a low-endemic district: an epidemiological aspect.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2023 |
[Domestic Malaria Cases in Kayseri Province].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Travel | 2023 |
Prevalence, trends and associated factors of malaria in the Shai-Osudoku District Hospital, Ghana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Cross-Sectional Studies; Ghana; Hospitals, District; Humans; Infant; Malaria; Malaria, Falciparum; Middle Aged; Prevalence; Young Adult | 2023 |
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |
Cost of inappropriate prescriptions for uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ghana; Humans; Inappropriate Prescribing; Malaria; Retrospective Studies | 2023 |
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Uganda | 2023 |
Vitamin C-rich juice co-administration with artemether-lumefantrine ameliorates oxido-inflammatory responses in Plasmodium berghei-infected mice.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ascorbic Acid; Interleukin-6; Malaria; Malondialdehyde; Mice; Parasitemia; Plasmodium berghei; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Benin; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
[A Marginal Case of Malaria: An Interesting Malaria Story of Cameroon Origin].
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cameroon; Coinfection; Humans; Malaria; Malaria, Vivax; Male; Middle Aged; Plasmodium; Plasmodium falciparum; Plasmodium vivax; Real-Time Polymerase Chain Reaction | 2023 |
Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Prescriptions; Prospective Studies; Tanzania; World Health Organization | 2023 |
Malaria in Pregnancy: Key Points for the Neonatologist.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Female; Humans; Infant; Infant, Newborn; Malaria; Neonatologists; Pregnancy; Premature Birth | 2023 |
Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Case Management; Cross-Sectional Studies; Female; Humans; Kenya; Malaria; Pregnancy; Quinine | 2023 |
Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Health Personnel; Humans; Kenya; Malaria; Pharmaceutical Preparations; Pregnancy; Quinine | 2023 |
The public health response to a Plasmodium malariae outbreak in Penampang district, Sabah during a COVID-19 movement control order.
Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; COVID-19; Disease Outbreaks; Female; Humans; Malaria; Malaysia; Male; Mosquito Vectors; Pandemics; Plasmodium knowlesi; Plasmodium malariae; Public Health | 2023 |
Adherence to national malaria treatment guidelines in private drug outlets: a cross-sectional survey in the malaria-endemic Kisumu County, Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Fever; Humans; Kenya; Malaria; Surveys and Questionnaires | 2023 |
Knowledge and practices of private pharmacy auxiliaries on malaria in Abidjan, Côte d'Ivoire.
Topics: Antimalarials; Artemether; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Female; Humans; Lumefantrine; Malaria; Pharmacies; Pharmacy; Pregnancy; Surveys and Questionnaires | 2023 |
Attractive targeted sugar bait: the pyrrole insecticide chlorfenapyr and the anti-malarial pharmaceutical artemether-lumefantrine arrest Plasmodium falciparum development inside wild pyrethroid-resistant Anopheles gambiae s.s. mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Carbohydrates; Female; Humans; Insecticide Resistance; Insecticides; Malaria; Malaria, Falciparum; Male; Mosquito Control; Mosquito Vectors; Plasmodium falciparum; Pyrethrins; Sugars | 2023 |
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult | 2020 |
Post-Marketing Surveillance of Quality of Artemether Injection Marketed in Southwest Nigeria.
Topics: Antimalarials; Artemether; Cross-Sectional Studies; Geography; Humans; Injections; Malaria; Nigeria; Product Surveillance, Postmarketing | 2020 |
Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Malaria; Placenta; Pregnancy; Rabbits; Rats; Teratogens | 2020 |
Self-medication practice with antimalarials & the determinants of malaria treatment-seeking behavior among postpartum mothers in a rural community in Nigeria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Malaria; Mothers; Nigeria; Postpartum Period; Rural Population | 2021 |
Artemether-Loaded Zein Nanoparticles: An Innovative Intravenous Dosage Form for the Management of Severe Malaria.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Caseins; Delayed-Action Preparations; Malaria; Nanoparticles; Rats; Rats, Sprague-Dawley; Zein | 2021 |
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Feasibility Studies; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy | 2021 |
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines | 2021 |
Antimalarial drug resistance markers in human immunodeficiency virus (HIV)-positive and HIV-negative adults with asymptomatic malaria infections in Port Harcourt, Nigeria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Drug Resistance; HIV; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Protozoan Proteins | 2021 |
Heparin-decorated nanostructured lipid carriers of artemether-protoporphyrin IX-transferrin combination for therapy of malaria.
Topics: Animals; Artemether; Drug Carriers; Heparin; Lipids; Malaria; Mice; Nanostructures; Particle Size; Protoporphyrins; Rats; Transferrin | 2021 |
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium knowlesi | 2022 |
An assessment of the knowledge, practices and resources during the delivery of malaria health care services among private health care practitioners: a cross section study in the Mid-Western Region of Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Delivery of Health Care; Health Facilities; Humans; Malaria; Private Sector; Uganda | 2021 |
Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Colombia; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Young Adult | 2017 |
On assessing bioequivalence and interchangeability between generics based on indirect comparisons.
Topics: Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Computer Simulation; Confidence Intervals; Drugs, Generic; Ethanolamines; Fluorenes; HIV Infections; Humans; Lamivudine; Lumefantrine; Malaria; Models, Statistical; Therapeutic Equivalency; Zidovudine | 2017 |
Market for Artemether-Lumefantrine to treat childhood malaria in a district of southern Mozambique.
Topics: Antimalarials; Artemether; Child; Child, Preschool; Drug Therapy, Combination; Female; Financing, Personal; Health Services Needs and Demand; Humans; Infant; Lumefantrine; Malaria; Male; Mozambique; Outcome Assessment, Health Care; Regression Analysis | 2017 |
Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery.
Topics: Animals; Antimalarials; Artemether; Drug Liberation; Liposomes; Lumefantrine; Malaria; Mice; Nanoparticles; Tissue Distribution | 2019 |
The course of pregnancy and delivery in a patient with malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Infant, Newborn; Malaria; Male; Poland; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Tanzania; Travel | 2017 |
Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Cardiotoxicity; Disease Models, Animal; Electrocardiography; Female; Malaria; Male; Mice; Mice, Inbred C57BL; Nanocapsules; Plasmodium berghei | 2018 |
Level A in vitro-in vivo correlation: Application to establish a dissolution test for artemether and lumefantrine tablets.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Solubility; Tablets; Young Adult | 2018 |
Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Biological Availability; Drug Delivery Systems; Emulsions; Lumefantrine; Malaria; Male; Particle Size; Rats | 2018 |
Quality of the antimalarial medicine artemether - lumefantrine in 8 cities of the Democratic Republic of the Congo.
Topics: Antimalarials; Artemether; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Congo; Drug Contamination; Drug Stability; Humans; Lumefantrine; Malaria; Quality Control | 2018 |
Assessing the consistency assumptions underlying network meta-regression using aggregate data.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Bayes Theorem; Data Interpretation, Statistical; Humans; Malaria; Models, Statistical; Network Meta-Analysis; Odds Ratio; Quinine; Regression Analysis; Reproducibility of Results; Research Design | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
[The treatment of malaria].
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Malaria Vaccines; Male; Netherlands; Pregnancy; Travel | 2019 |
Resolution pattern of jaundice among children presenting with severe malaria in rural South-West Nigeria.
Topics: Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Jaundice; Malaria; Male; Nigeria; Quinine; Rural Population; Time Factors; Treatment Outcome | 2012 |
Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.
Topics: Animals; Antimalarials; Antioxidants; Artemether; Artemisinins; Chloroquine; Erythrocytes; Liver; Malaria; Methylene Blue; Mice; Oxidative Stress; Plasmodium yoelii | 2013 |
Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Disease Models, Animal; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei | 2013 |
Plasmodium knowlesi infection imported to Germany, January 2013.
Topics: Acute Kidney Injury; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Germany; Humans; Lumefantrine; Malaria; Microscopy; Middle Aged; Plasmodium knowlesi; Polymerase Chain Reaction; Thailand; Travel; Treatment Outcome | 2013 |
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Carbamates; Carbon; Crystallography, X-Ray; Dimerization; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Molecular Conformation; Plasmodium berghei; Structure-Activity Relationship; Survival Analysis | 2014 |
The effect of lopinavir/ritonavir on the antimalarial activity of artemether or artemether/lumefantrine in a mouse model of Plasmodium berghei.
Topics: Animals; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Coinfection; Disease Models, Animal; Drug Combinations; Drug Interactions; Ethanolamines; Fluorenes; HIV Infections; Lopinavir; Malaria; Mice; Plasmodium berghei; Ritonavir | 2015 |
Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.
Topics: Administration, Rectal; Age Factors; Animals; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Azithromycin; Biological Availability; Capsules; Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Drug Combinations; Endemic Diseases; Excipients; Humans; Malaria; Powder Diffraction; Rabbits; Solubility; Tablets; Technology, Pharmaceutical | 2014 |
Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Carriers; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Mice; Nanostructures; Particle Size; Plasmodium berghei | 2016 |
Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Coinfection; Diagnostic Tests, Routine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Longitudinal Studies; Lumefantrine; Malaria; Male; Plasmodium; Plasmodium falciparum; Plasmodium ovale; Point-of-Care Systems; Prevalence; Uganda | 2014 |
Enhanced antimalarial activity by a novel artemether-lumefantrine lipid emulsion for parenteral administration.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Emulsions; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Plasmodium berghei | 2014 |
[Diagnosis of the first imported case of Plasmodium ovale infection at Guangdong Port].
Topics: Artemether; Artemisinins; China; DNA Primers; Humans; Malaria; Microscopy; Myanmar; Plasmodium ovale; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction | 2014 |
Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Plasmodium berghei; Rifampin; Survival Analysis | 2014 |
Antiplasmodial activity-aided isolation and identification of quercetin-4'-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Cell Line; Chloroquine; Chromolaena; Drug Resistance; Female; Inhibitory Concentration 50; Kaempferols; Lethal Dose 50; Malaria; Malaria, Falciparum; Male; Methyl Ethers; Mice; Plant Extracts; Plant Leaves; Plasmodium berghei; Plasmodium falciparum; Quercetin; Random Allocation | 2014 |
Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.
Topics: Adamantane; Animals; Anopheles; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Indoles; Insect Vectors; Lumefantrine; Malaria; Mice; Peroxides; Plasmodium berghei; Primaquine; Spiro Compounds | 2015 |
Formulation, characterization and anti-malarial activity of homolipid-based artemether microparticles.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Drug Carriers; Fats; Malaria; Mice; Parasitemia; Particle Size; Phosphatidylcholines; Plasmodium berghei; Seeds; Solubility | 2015 |
[Effect of a large scale community-based distribution of artemether-lumefantrine on its therapeutic efficacy among children living in a rural area of Burkina Faso].
Topics: Antimalarials; Artemether; Artemisinins; Burkina Faso; Child, Preschool; Delivery of Health Care; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Population Density; Randomized Controlled Trials as Topic; Rural Population; Sample Size; Treatment Outcome | 2015 |
CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
Topics: Alkynes; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Case-Control Studies; Coinfection; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Antagonism; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genotype; HIV Infections; Humans; Lumefantrine; Malaria; Nevirapine; Prospective Studies | 2016 |
The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya.
Topics: Antimalarials; Artemether; Artemisinins; Awareness; Caregivers; Child, Preschool; Community Health Services; Community Participation; Cross-Sectional Studies; Ethanolamines; Family Characteristics; Female; Fever; Fluorenes; Humans; Infant; Infant, Newborn; Kenya; Lumefantrine; Malaria; Male; Patient Acceptance of Health Care | 2015 |
Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Health Services Accessibility; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Private Sector; Rural Population; Surveys and Questionnaires; Tanzania | 2012 |
The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia.
Topics: Antimalarials; Artemether; Artemisinins; Delivery of Health Care; Drugs, Essential; Ethanolamines; Fluorenes; Health Facilities; Health Planning; Humans; Lumefantrine; Malaria; Materials Management, Hospital; Models, Statistical; Pharmaceutical Services; Plasmodium falciparum; Workforce | 2016 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
Teratogenicity of Artemether-Clindamycin Nanostructured Lipid Carriers in Rats.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Clindamycin; Diglycerides; Drug Carriers; Female; Malaria; Male; Maternal-Fetal Exchange; Mice; Monoglycerides; Nanostructures; Pregnancy; Rats, Sprague-Dawley | 2016 |
Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Carriers; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lipids; Lumefantrine; Malaria; Male; Mice; Nanostructures; Plasmodium berghei; Rats; Rats, Wistar; Treatment Outcome | 2016 |
Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia.
Topics: Administrative Personnel; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Ethiopia; Female; Health Personnel; Humans; Injections, Intramuscular; Interviews as Topic; Malaria; Male; Quinine; Young Adult | 2016 |
Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
Topics: Angola; Antimalarials; Artemether; Artemisinins; Drug Costs; Drug Therapy, Combination; Ethanolamines; Financing, Government; Fluorenes; Health Services Accessibility; Humans; Lumefantrine; Malaria; Marketing of Health Services; Pharmacies; Private Sector | 2016 |
Spontaneous splenic rupture from Plasmodium ovalae malaria.
Topics: Abdomen; Adult; Africa, Central; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Endemic Diseases; Ethanolamines; Fluorenes; Humans; Laparoscopy; Lumefantrine; Malaria; Male; Plasmodium ovale; Splenectomy; Splenic Rupture; Tomography, X-Ray Computed | 2017 |
Engineering of microcomplex of artemether and lumefantrine for effective drug treatment in malaria.
Topics: Antimalarials; Artemether; Artemisinins; beta-Cyclodextrins; Citric Acid; Drug Carriers; Drug Interactions; Drug Liberation; Ethanolamines; Fluorenes; Lumefantrine; Malaria; Microspheres; Particle Size; Pyrrolidines; Vinyl Compounds | 2017 |
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Malaria; Mice; Mice, Inbred BALB C; Quinolines | 2017 |
Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Emulsions; Lethal Dose 50; Malaria; Male; Mice; Oils; Particle Size; Plasmodium berghei; Solubility; Surface-Active Agents; Toxicity Tests | 2008 |
Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Emulsions; Lethal Dose 50; Malaria; Male; Mice; Oils; Particle Size; Plasmodium berghei; Solubility; Surface-Active Agents | 2008 |
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Drug Design; Emulsions; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Injections; Liposomes; Malaria; Male; Mice; Particle Size; Plasmodium berghei; Survival Analysis | 2008 |
Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Ethanolamines; Fluorenes; Guideline Adherence; Health Policy; Health Services Research; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Middle Aged; Uganda | 2008 |
Antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Therapy, Combination; Ethanolamines; Fats; Fluorenes; Humans; Lumefantrine; Malaria; Quinolines; Treatment Failure | 2009 |
Advances in global biotechnology and local resources to treat malaria.
Topics: Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Drug Approval; Drug Resistance, Multiple; Drugs, Investigational; Global Health; Humans; Malaria; Minnesota; Phytotherapy | 2009 |
First artemisinin-based antimalarial combination approved for U.S. market.
Topics: Administration, Oral; Antimalarials; Artemether; Artemisinins; Drug Approval; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Tablets; United States; United States Food and Drug Administration | 2009 |
Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Formates; HIV Infections; Humans; Malaria; Models, Chemical; Quality Control; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2009 |
Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Carriers; Drug Compounding; Lipids; Malaria; Mice; Nanoparticles; Particle Size; Plasmodium berghei; Technology, Pharmaceutical | 2010 |
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Female; Fluorenes; Hospitals, Urban; Humans; Lumefantrine; Malaria; Malaysia; Microscopy; Middle Aged; Parasitemia; Patient Selection; Plasmodium knowlesi; Polymerase Chain Reaction; Quinine; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Survival Rate | 2011 |
Plasmodium knowlesi reinfection in human.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Blood Transfusion; Doxycycline; Ethanolamines; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria; Malaysia; Male; Mefloquine; Microscopy; Phylogeny; Plasmodium knowlesi; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Recurrence | 2011 |
Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Pyrimethamine; Refugees; Sulfadoxine; Tanzania; United States | 2011 |
Plasmodium species co-infection as a cause of treatment failure.
Topics: Antimalarials; Artemether; Artemisinins; Australia; Coinfection; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Plasmodium malariae; Travel; Treatment Outcome; Uganda | 2011 |
Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?
Topics: Adult; Animals; Antibodies, Protozoan; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Plasmodium falciparum; Plasmodium malariae | 2012 |
Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Treatment Outcome | 2012 |
Neurotoxicity and efficacy of arteether related to its exposure times and exposure levels in rodents.
Topics: Animals; Anorexia; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Availability; Malaria; Male; Mice; Muscle, Skeletal; Neurotoxins; Plasmodium berghei; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tissue Distribution | 2002 |
Recent studies have reported significant toxicity of artemisinin and its derivatives for schistosomula in various Schistosoma species.
Topics: Africa; Animals; Artemether; Artemisinins; Child; Clinical Trials as Topic; Female; Humans; Malaria; Male; Schistosomiasis; Schistosomicides; Sesquiterpenes | 2003 |
Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Disease Models, Animal; Drug Resistance; Female; Immunity, Innate; Malaria; Male; Mice; Mice, Inbred Strains; Naphthyridines; Plasmodium berghei; Sesquiterpenes | 2004 |
Laboratory evaluation of the ict malaria P.f./P.v. immunochromatographic test for detecting the panmalarial antigen using a rodent malaria model.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Chromatography; Disease Models, Animal; False Negative Reactions; False Positive Reactions; Female; Fructose-Bisphosphate Aldolase; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sesquiterpenes | 2004 |
Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Stability; Fluorine; Hydrolysis; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 2004 |
[Additive therapeutic effect of a combination of artemether and daphnetin against Plasmodium berghei in mice].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Malaria; Male; Mice; Plasmodium berghei; Sesquiterpenes; Umbelliferones | 2004 |
Treating severe malaria.
Topics: Administration, Rectal; Antimalarials; Artemether; Artemisinins; Child; Humans; Infusions, Intravenous; Malaria; Quinine; Sesquiterpenes; Suppositories | 2005 |
Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Malaria; Mice; Molecular Structure; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Sesquiterpenes | 2005 |
Examples of tropical disease control in the humanitarian medical programmes of MSF and Merlin.
Topics: Antimalarials; Artemether; Artemisinins; Attitude to Health; Child; Child, Preschool; Communicable Disease Control; Cross Infection; Eflornithine; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Lassa Fever; Lumefantrine; Malaria; Medical Missions; Pregnancy; Sierra Leone; Sudan; Trypanocidal Agents; Trypanosomiasis, African; Tuberculosis, Pulmonary; USSR | 2006 |
A case-control auditory evaluation of patients treated with artemether-lumefantrine.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Audiometry; Case-Control Studies; Child; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Hearing Loss; Humans; Lumefantrine; Malaria; Male; Middle Aged; Treatment Outcome | 2006 |
Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Humans; Intestines; Liver; Malaria; Mice; Parasitemia; Plasmodium berghei; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2006 |
Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana.
Topics: Antimalarials; Artemether; Artemisinins; Caregivers; Child, Preschool; Clinical Competence; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Feasibility Studies; Female; Fluorenes; Ghana; Home Nursing; Humans; Infant; Lumefantrine; Malaria; Male; Patient Acceptance of Health Care; Patient Compliance | 2006 |
First Brazilian experience with the use of artemether-lumefantrine (Coartem) a fixed-dosed ACT combination.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Brazil; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Time Factors; World Health Organization | 2006 |
The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemether; Artemisinins; Diagnostic Errors; Ethanolamines; Fever; Fluorenes; Health Care Costs; Humans; Kenya; Lumefantrine; Malaria; Microscopy; Models, Economic; Prevalence; Sensitivity and Specificity | 2006 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Changes in the visceral functions of Plasmodium berghei-infected and -uninfected rats following administration of artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drinking; Eating; Female; Malaria; Male; Plasmodium berghei; Rats; Rats, Wistar; Urine | 2006 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
[Artemether-lumefantrine, treatment of child more than 5 years old uncomplicated malaria in Tsevie's hospital (Togo)].
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Safety | 2007 |
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria.
Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Decision Trees; Diagnostic Tests, Routine; Ethanolamines; Fluorenes; Humans; L-Lactate Dehydrogenase; Lumefantrine; Malaria; Plasmodium; Protozoan Proteins; Sensitivity and Specificity; Uganda; Urban Population | 2008 |
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Case Management; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Government Programs; Guideline Adherence; Health Personnel; Humans; Kenya; Lumefantrine; Malaria; Male; Middle Aged; Rural Population; Surveys and Questionnaires | 2008 |
Malaria in Egypt, Saudi Arabia and Yemen: a clinical pilot study.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Egypt; Female; Humans; Infant; Malaria; Male; Mefloquine; Middle Aged; Pilot Projects; Quinine; Saudi Arabia; Severity of Illness Index; Yemen | 2007 |
[Antimalarial effect and toxicity of methyl-dihydro-artemisinine in animals (author's transl)].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Dogs; Female; Malaria; Male; Mice; Pyrans; Rabbits; Rats; Sesquiterpenes | 1981 |
[A combined regimen of pyronaridin-artemether-chloroquine (PAC) for the treatment of Plasmodium cynomolgi infection in the rhesus monkey].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Therapy, Combination; Macaca mulatta; Malaria; Naphthyridines; Pyrans; Sesquiterpenes | 1984 |
Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain Diseases; Child; Child, Preschool; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Sesquiterpenes | 1982 |
[Clinical study on the use of artemether in treating pernicious malaria].
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Malaria; Male; Middle Aged; Pyrans; Sesquiterpenes | 1982 |
[Complicated malaria tropica--therapy with artemether].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Cambodia; Critical Care; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Malaria; Malaria, Cerebral; Male; Pregnancy; Pregnancy Complications, Parasitic; Sesquiterpenes | 1994 |
Antimalarial activity of dihydroartemisinin derivatives by transdermal application.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Gels; Malaria; Mice; Plasmodium berghei; Sesquiterpenes; Structure-Activity Relationship | 1994 |
[Studies on the establishment of malarial animal model of short-term relapse. IV. Short-term relapse in rhesus monkeys infected with sporozoites of Plasmodium cynomolgi].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Erythrocytes; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence; Sesquiterpenes | 1993 |
[Studies on the establishment of malarial animal model of short-term relapse. III. Combined therapy with pyronaridine-artemether-chloroquine for parasitemia clearance].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence; Sesquiterpenes | 1993 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
Ammunition against malaria.
Topics: Antimalarials; Artemether; Artemisinins; Canada; Humans; Malaria; Sesquiterpenes | 2001 |
Potent antimalarial activities of polyether antibiotic, X-206.
Topics: Actinomycetales; Animals; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Death; Cell Line; Chloroquine; Drug Resistance; Embryo, Mammalian; Embryo, Nonmammalian; Ethers, Cyclic; Humans; Malaria; Mice; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes | 2001 |
A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Female; Isoquinolines; Life Cycle Stages; Malaria; Mice; Parasitemia; Plasmodium chabaudi; Sesquiterpenes | 2001 |
Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Liposomes; Malaria; Mice; Parasitemia; Plasmodium chabaudi; Secondary Prevention; Sesquiterpenes; Spectrophotometry, Ultraviolet | 2002 |
Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman.
Topics: Antimalarials; Artemether; Artemisinins; Female; Follow-Up Studies; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Sesquiterpenes | 1989 |
[Effects of artemether on red blood cell immunity in malaria].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Erythrocyte Membrane; Female; Macaca mulatta; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
Experimental studies on the antimalarial activity estimation by artesunate and artemether preparations per skin absorption.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Female; Malaria; Male; Mice; Plasmodium berghei; Sesquiterpenes; Skin Absorption | 1988 |
The combined use of artemether, sulfadoxine and pyrimethamine in the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Sulfanilamides; Time Factors | 1988 |
[Combined use of artemether with other antimalarials in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Humans; Malaria; Middle Aged; Nitroquinolines; Plasmodium falciparum; Primaquine; Pyrans; Sesquiterpenes; Sulfadoxine | 1987 |
[Clinical study on the treatment of malaria with artemether and artesunate].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Recurrence; Sesquiterpenes | 1988 |
[Development of a qinghaosu-resistant line of Plasmodium berghei ANKA and N strain].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Microbial; Malaria; Male; Mice; Plasmodium berghei; Primaquine; Pyrans; Sesquiterpenes | 1986 |
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Malaria; Male; Mice; Pigments, Biological; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
Sensitivity of malaria parasites to artemether (qinghaosu derivative) depends on host cell age.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Erythrocyte Aging; Erythrocytes; Malaria; Mice; Plasmodium berghei; Sesquiterpenes | 1987 |
The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
Topics: Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 1986 |
A case of black water fever treated with peritoneal dialysis and artemether (quinghaosu derivative).
Topics: Artemether; Artemisinins; Blackwater Fever; Humans; Malaria; Middle Aged; Peritoneal Dialysis; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1987 |
[The combined use of artemether, sulfadoxine, pyrimethamine and primaquine in the treatment of chloroquine-resistant falciparum malaria].
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Primaquine; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1985 |
Clinical studies of treatment of falciparum malaria with artemether, a derivative of qinghaosu.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Plasmodium falciparum; Pyrans; Sesquiterpenes | 1985 |